Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.31K % -7.97%
Debt-to-equity 5.02 % +6.59%
Return On Equity -39.6 % -40.4%
Return On Assets -37.7 % -40%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.4M shares +15.2%
Common Stock, Shares, Outstanding 70.3M shares +15.2%
Entity Public Float 409M USD +774%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 74.5M shares +4.34%
Weighted Average Number of Shares Outstanding, Diluted 74.5M shares +4.34%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 39M USD +53.5%
Costs and Expenses 108M USD +36.2%
Operating Income (Loss) -108M USD -36.2%
Nonoperating Income (Expense) 12.6M USD +60.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -95.6M USD -33.6%
Income Tax Expense (Benefit) 265K USD -42.8%
Net Income (Loss) Attributable to Parent -95.9M USD -33.1%
Earnings Per Share, Basic -1.32 USD/shares -16.8%
Earnings Per Share, Diluted -1.32 USD/shares -16.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.5M USD +13.1%
Marketable Securities, Current 134M USD -34.6%
Assets, Current 230M USD -20.1%
Property, Plant and Equipment, Net 370K USD -37.3%
Operating Lease, Right-of-Use Asset 217K USD -71.3%
Other Assets, Noncurrent 55K USD +52.8%
Assets 231M USD -20.3%
Accounts Payable, Current 1.87M USD -66.2%
Employee-related Liabilities, Current 3.11M USD +74%
Liabilities, Current 11M USD -23.1%
Accrued Income Taxes, Noncurrent 1.24M USD +14.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 12.2M USD -21.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -443K USD +42.8%
Retained Earnings (Accumulated Deficit) -378M USD -34%
Stockholders' Equity Attributable to Parent 219M USD -20.2%
Liabilities and Equity 231M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD -58.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 8M USD -71.4%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 70.3M shares +15.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD -136%
Deferred Tax Assets, Valuation Allowance 59.6M USD +41.3%
Deferred Tax Assets, Gross 182K USD -38.1%
Operating Lease, Liability 249K USD -71.6%
Payments to Acquire Property, Plant, and Equipment 29K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -95.6M USD -33.5%
Lessee, Operating Lease, Liability, to be Paid 252K USD -72.4%
Property, Plant and Equipment, Gross 2.12M USD -2.04%
Operating Lease, Liability, Current 249K USD -61.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 850K USD +27.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD -91.9%
Deferred Tax Assets, Operating Loss Carryforwards 19.9M USD +44%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 7.51M USD +18.8%
Additional Paid in Capital 597M USD +7.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 82K USD +7.9%
Share-based Payment Arrangement, Expense 25.8M USD +90.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%